Table of Contents 1 Market Overview 1.1 Circulating Tumor Cell Diagnostics Introduction 1.2 Market Analysis by Type 1.2.1 CTC Enrichment 1.2.2 CTC Detection 1.2.3 CTC Analysis 1.3 Market Analysis by Applications 1.3.1 Tumorigenesis research 1.3.2 EMT biomarkers development 1.3.3 Cancer stem cell research 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Janssen Diagnostics 2.1.1 Business Overview 2.1.2 Circulating Tumor Cell Diagnostics Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Advanced Cell Diagnostics 2.2.1 Business Overview 2.2.2 Circulating Tumor Cell Diagnostics Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Aviva Biosciences 2.3.1 Business Overview 2.3.2 Circulating Tumor Cell Diagnostics Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Biocept Inc 2.4.1 Business Overview 2.4.2 Circulating Tumor Cell Diagnostics Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Biofluidica Inc. 2.5.1 Business Overview 2.5.2 Circulating Tumor Cell Diagnostics Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 CellTraffix Inc. 2.6.1 Business Overview 2.6.2 Circulating Tumor Cell Diagnostics Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Clearbridge BioMedics Pte Ltd 2.7.1 Business Overview 2.7.2 Circulating Tumor Cell Diagnostics Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Epic Sciences Inc. 2.8.1 Business Overview 2.8.2 Circulating Tumor Cell Diagnostics Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Fluxion Biosciences Inc. 2.9.1 Business Overview 2.9.2 Circulating Tumor Cell Diagnostics Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 ScreenCell 2.10.1 Business Overview 2.10.2 Circulating Tumor Cell Diagnostics Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 ScreenCell Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Silicon Biosystems 2.11.1 Business Overview 2.11.2 Circulating Tumor Cell Diagnostics Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Silicon Biosystems Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Sysmex Corporation 2.12.1 Business Overview 2.12.2 Circulating Tumor Cell Diagnostics Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Sysmex Corporation Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Greiner Bio-One GmbH 2.13.1 Business Overview 2.13.2 Circulating Tumor Cell Diagnostics Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 AdnaGen AG 2.14.1 Business Overview 2.14.2 Circulating Tumor Cell Diagnostics Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 AdnaGen AG Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Apocell Inc 2.15.1 Business Overview 2.15.2 Circulating Tumor Cell Diagnostics Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Apocell Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Biocep Ltd 2.16.1 Business Overview 2.16.2 Circulating Tumor Cell Diagnostics Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Biocep Ltd Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Canopus Bioscience Ltd 2.17.1 Business Overview 2.17.2 Circulating Tumor Cell Diagnostics Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Creatv Microtech Inc 2.18.1 Business Overview 2.18.2 Circulating Tumor Cell Diagnostics Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 Ikonisys Inc 2.19.1 Business Overview 2.19.2 Circulating Tumor Cell Diagnostics Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20 IV Diagnostics Inc 2.20.1 Business Overview 2.20.2 Circulating Tumor Cell Diagnostics Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21 Miltenyi Biotech GmbH 2.21.1 Business Overview 2.2.2 Circulating Tumor Cell Diagnostics Type and Applications 2.21.2.1 Product A 2.21.2.2 Product B 2.21.3 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.22 Nanostring Technologies Inc 2.22.1 Business Overview 2.22.2 Circulating Tumor Cell Diagnostics Type and Applications 2.22.2.1 Product A 2.22.2.2 Product B 2.22.3 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.23 Rarecells Diagnostics. 2.23.1 Business Overview 2.23.2 Circulating Tumor Cell Diagnostics Type and Applications 2.23.2.1 Product A 2.23.2.2 Product B 2.23.3 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.24 Vitatex Inc 2.24.1 Business Overview 2.24.2 Circulating Tumor Cell Diagnostics Type and Applications 2.24.2.1 Product A 2.24.2.2 Product B 2.24.3 Vitatex Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Circulating Tumor Cell Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Circulating Tumor Cell Diagnostics Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Circulating Tumor Cell Diagnostics Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Circulating Tumor Cell Diagnostics Manufacturer Market Share in 2017 3.3.2 Top 6 Circulating Tumor Cell Diagnostics Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Circulating Tumor Cell Diagnostics Market Analysis by Regions 4.1 Global Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Regions 4.1.1 Global Circulating Tumor Cell Diagnostics Sales and Market Share by Regions (2013-2018) 4.1.2 Global Circulating Tumor Cell Diagnostics Revenue and Market Share by Regions (2013-2018) 4.2 North America Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 4.3 Europe Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 4.5 South America Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 5 North America Circulating Tumor Cell Diagnostics by Countries 5.1 North America Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Countries 5.1.1 North America Circulating Tumor Cell Diagnostics Sales and Market Share by Countries (2013-2018) 5.1.2 North America Circulating Tumor Cell Diagnostics Revenue and Market Share by Countries (2013-2018) 5.2 United States Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 5.3 Canada Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 5.4 Mexico Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 6 Europe Circulating Tumor Cell Diagnostics by Countries 6.1 Europe Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Countries 6.1.1 Europe Circulating Tumor Cell Diagnostics Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Circulating Tumor Cell Diagnostics Revenue and Market Share by Countries (2013-2018) 6.2 Germany Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 6.3 UK Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 6.4 France Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 6.5 Russia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 6.6 Italy Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 7 Asia-Pacific Circulating Tumor Cell Diagnostics by Countries 7.1 Asia-Pacific Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Circulating Tumor Cell Diagnostics Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Circulating Tumor Cell Diagnostics Revenue and Market Share by Countries (2013-2018) 7.2 China Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 7.3 Japan Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 7.4 Korea Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 7.5 India Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 8 South America Circulating Tumor Cell Diagnostics by Countries 8.1 South America Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Countries 8.1.1 South America Circulating Tumor Cell Diagnostics Sales and Market Share by Countries (2013-2018) 8.1.2 South America Circulating Tumor Cell Diagnostics Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 8.3 Argentina Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 8.4 Colombia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 9 Middle East and Africa Circulating Tumor Cell Diagnostics by Countries 9.1 Middle East and Africa Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Circulating Tumor Cell Diagnostics Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Circulating Tumor Cell Diagnostics Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 9.3 UAE Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 9.4 Egypt Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 9.5 Nigeria Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 9.6 South Africa Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) 10 Global Circulating Tumor Cell Diagnostics Market Segment by Type 10.1 Global Circulating Tumor Cell Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Circulating Tumor Cell Diagnostics Sales and Market Share by Type (2013-2018) 10.1.2 Global Circulating Tumor Cell Diagnostics Revenue and Market Share by Type (2013-2018) 10.2 CTC Enrichment Sales Growth and Price 10.2.1 Global CTC Enrichment Sales Growth (2013-2018) 10.2.2 Global CTC Enrichment Price (2013-2018) 10.3 CTC Detection Sales Growth and Price 10.3.1 Global CTC Detection Sales Growth (2013-2018) 10.3.2 Global CTC Detection Price (2013-2018) 10.4 CTC Analysis Sales Growth and Price 10.4.1 Global CTC Analysis Sales Growth (2013-2018) 10.4.2 Global CTC Analysis Price (2013-2018) 11 Global Circulating Tumor Cell Diagnostics Market Segment by Application 11.1 Global Circulating Tumor Cell Diagnostics Sales Market Share by Application (2013-2018) 11.2 Tumorigenesis research Sales Growth (2013-2018) 11.3 EMT biomarkers development Sales Growth (2013-2018) 11.4 Cancer stem cell research Sales Growth (2013-2018) 11.5 Others Sales Growth (2013-2018) 12 Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) 12.1 Global Circulating Tumor Cell Diagnostics Sales, Revenue and Growth Rate (2018-2023) 12.2 Circulating Tumor Cell Diagnostics Market Forecast by Regions (2018-2023) 12.2.1 North America Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) 12.2.2 Europe Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) 12.2.3 Asia-Pacific Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) 12.2.4 South America Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) 12.2.5 Middle East and Africa Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) 12.3 Circulating Tumor Cell Diagnostics Market Forecast by Type (2018-2023) 12.3.1 Global Circulating Tumor Cell Diagnostics Sales Forecast by Type (2018-2023) 12.3.2 Global Circulating Tumor Cell Diagnostics Market Share Forecast by Type (2018-2023) 12.4 Circulating Tumor Cell Diagnostics Market Forecast by Application (2018-2023) 12.4.1 Global Circulating Tumor Cell Diagnostics Sales Forecast by Application (2018-2023) 12.4.2 Global Circulating Tumor Cell Diagnostics Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Circulating Tumor Cell Diagnostics Picture Table Product Specifications of Circulating Tumor Cell Diagnostics Figure Global Sales Market Share of Circulating Tumor Cell Diagnostics by Types in 2017 Table Circulating Tumor Cell Diagnostics Types for Major Manufacturers Figure CTC Enrichment Picture Figure CTC Detection Picture Figure CTC Analysis Picture Figure Circulating Tumor Cell Diagnostics Sales Market Share by Applications in 2017 Figure Tumorigenesis research Picture Figure EMT biomarkers development Picture Figure Cancer stem cell research Picture Figure Others Picture Figure United States Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Canada Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Germany Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure France Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure UK Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Russia Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Italy Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure China Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Japan Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Korea Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure India Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Circulating Tumor Cell Diagnostics Revenue (Value) and Growth Rate (2013-2023) Table Janssen Diagnostics Basic Information, Manufacturing Base and Competitors Table Janssen Diagnostics Circulating Tumor Cell Diagnostics Type and Applications Table Janssen Diagnostics Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Advanced Cell Diagnostics Basic Information, Manufacturing Base and Competitors Table Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Type and Applications Table Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Aviva Biosciences Basic Information, Manufacturing Base and Competitors Table Aviva Biosciences Circulating Tumor Cell Diagnostics Type and Applications Table Aviva Biosciences Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biocept Inc Basic Information, Manufacturing Base and Competitors Table Biocept Inc Circulating Tumor Cell Diagnostics Type and Applications Table Biocept Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biofluidica Inc. Basic Information, Manufacturing Base and Competitors Table Biofluidica Inc. Circulating Tumor Cell Diagnostics Type and Applications Table Biofluidica Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table CellTraffix Inc. Basic Information, Manufacturing Base and Competitors Table CellTraffix Inc. Circulating Tumor Cell Diagnostics Type and Applications Table CellTraffix Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Clearbridge BioMedics Pte Ltd Basic Information, Manufacturing Base and Competitors Table Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Type and Applications Table Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Epic Sciences Inc. Basic Information, Manufacturing Base and Competitors Table Epic Sciences Inc. Circulating Tumor Cell Diagnostics Type and Applications Table Epic Sciences Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Fluxion Biosciences Inc. Basic Information, Manufacturing Base and Competitors Table Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Type and Applications Table Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ScreenCell Basic Information, Manufacturing Base and Competitors Table ScreenCell Circulating Tumor Cell Diagnostics Type and Applications Table ScreenCell Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Silicon Biosystems Basic Information, Manufacturing Base and Competitors Table Silicon Biosystems Circulating Tumor Cell Diagnostics Type and Applications Table Silicon Biosystems Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sysmex Corporation Basic Information, Manufacturing Base and Competitors Table Sysmex Corporation Circulating Tumor Cell Diagnostics Type and Applications Table Sysmex Corporation Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Greiner Bio-One GmbH Basic Information, Manufacturing Base and Competitors Table Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Type and Applications Table Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AdnaGen AG Basic Information, Manufacturing Base and Competitors Table AdnaGen AG Circulating Tumor Cell Diagnostics Type and Applications Table AdnaGen AG Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Apocell Inc Basic Information, Manufacturing Base and Competitors Table Apocell Inc Circulating Tumor Cell Diagnostics Type and Applications Table Apocell Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biocep Ltd Basic Information, Manufacturing Base and Competitors Table Biocep Ltd Circulating Tumor Cell Diagnostics Type and Applications Table Biocep Ltd Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Canopus Bioscience Ltd Basic Information, Manufacturing Base and Competitors Table Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Type and Applications Table Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Creatv Microtech Inc Basic Information, Manufacturing Base and Competitors Table Creatv Microtech Inc Circulating Tumor Cell Diagnostics Type and Applications Table Creatv Microtech Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Ikonisys Inc Basic Information, Manufacturing Base and Competitors Table Ikonisys Inc Circulating Tumor Cell Diagnostics Type and Applications Table Ikonisys Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table IV Diagnostics Inc Basic Information, Manufacturing Base and Competitors Table IV Diagnostics Inc Circulating Tumor Cell Diagnostics Type and Applications Table IV Diagnostics Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Miltenyi Biotech GmbH Basic Information, Manufacturing Base and Competitors Table Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Type and Applications Table Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Nanostring Technologies Inc Basic Information, Manufacturing Base and Competitors Table Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Type and Applications Table Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Rarecells Diagnostics. Basic Information, Manufacturing Base and Competitors Table Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Type and Applications Table Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Vitatex Inc Basic Information, Manufacturing Base and Competitors Table Vitatex Inc Circulating Tumor Cell Diagnostics Type and Applications Table Vitatex Inc Circulating Tumor Cell Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Circulating Tumor Cell Diagnostics Sales by Manufacturer (2016-2017) Figure Global Circulating Tumor Cell Diagnostics Sales Market Share by Manufacturer in 2016 Figure Global Circulating Tumor Cell Diagnostics Sales Market Share by Manufacturer in 2017 Table Global Circulating Tumor Cell Diagnostics Revenue by Manufacturer (2016-2017) Figure Global Circulating Tumor Cell Diagnostics Revenue Market Share by Manufacturer in 2016 Figure Global Circulating Tumor Cell Diagnostics Revenue Market Share by Manufacturer in 2017 Figure Top 3 Circulating Tumor Cell Diagnostics Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Circulating Tumor Cell Diagnostics Manufacturer (Revenue) Market Share in 2017 Figure Global Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Global Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018) Table Global Circulating Tumor Cell Diagnostics Sales by Regions (2013-2018) Table Global Circulating Tumor Cell Diagnostics Sales Market Share by Regions (2013-2018) Table Global Circulating Tumor Cell Diagnostics Revenue by Regions (2013-2018) Figure Global Circulating Tumor Cell Diagnostics Revenue Market Share by Regions in 2013 Figure Global Circulating Tumor Cell Diagnostics Revenue Market Share by Regions in 2017 Figure North America Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Europe Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Asia-Pacific Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure South America Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Middle East and Africa Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure North America Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018) Table North America Circulating Tumor Cell Diagnostics Sales by Countries (2013-2018) Table North America Circulating Tumor Cell Diagnostics Sales Market Share by Countries (2013-2018) Figure North America Circulating Tumor Cell Diagnostics Sales Market Share by Countries in 2013 Figure North America Circulating Tumor Cell Diagnostics Sales Market Share by Countries in 2017 Table North America Circulating Tumor Cell Diagnostics Revenue by Countries (2013-2018) Table North America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2013-2018) Figure North America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2013 Figure North America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2017 Figure United States Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Canada Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Mexico Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Europe Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018) Table Europe Circulating Tumor Cell Diagnostics Sales by Countries (2013-2018) Table Europe Circulating Tumor Cell Diagnostics Sales Market Share by Countries (2013-2018) Table Europe Circulating Tumor Cell Diagnostics Revenue by Countries (2013-2018) Figure Europe Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2016 Figure Europe Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2017 Figure Germany Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure UK Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure France Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Russia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Italy Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Asia-Pacific Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018) Table Asia-Pacific Circulating Tumor Cell Diagnostics Sales by Countries (2013-2018) Table Asia-Pacific Circulating Tumor Cell Diagnostics Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Circulating Tumor Cell Diagnostics Sales Market Share by Countries 2017 Table Asia-Pacific Circulating Tumor Cell Diagnostics Revenue by Countries (2013-2018) Figure Asia-Pacific Circulating Tumor Cell Diagnostics Revenue Market Share by Countries 2017 Figure China Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Japan Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Korea Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure India Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Southeast Asia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure South America Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018) Table South America Circulating Tumor Cell Diagnostics Sales by Countries (2013-2018) Table South America Circulating Tumor Cell Diagnostics Sales Market Share by Countries (2013-2018) Figure South America Circulating Tumor Cell Diagnostics Sales Market Share by Countries in 2017 Table South America Circulating Tumor Cell Diagnostics Revenue by Countries (2013-2018) Table South America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2013-2018) Figure South America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2017 Figure Brazil Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Argentina Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Colombia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Middle East and Africa Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018) Table Middle East and Africa Circulating Tumor Cell Diagnostics Sales by Countries (2013-2018) Table Middle East and Africa Circulating Tumor Cell Diagnostics Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Circulating Tumor Cell Diagnostics Sales Market Share by Countries in 2017 Table Middle East and Africa Circulating Tumor Cell Diagnostics Revenue by Countries (2013-2018) Table Middle East and Africa Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2013 Figure Middle East and Africa Circulating Tumor Cell Diagnostics Revenue Market Share by Countries in 2017 Figure Saudi Arabia Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure UAE Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Egypt Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure Nigeria Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Figure South Africa Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018) Table Global Circulating Tumor Cell Diagnostics Sales by Type (2013-2018) Table Global Circulating Tumor Cell Diagnostics Sales Share by Type (2013-2018) Table Global Circulating Tumor Cell Diagnostics Revenue by Type (2013-2018) Table Global Circulating Tumor Cell Diagnostics Revenue Share by Type (2013-2018) Figure Global CTC Enrichment Sales Growth (2013-2018) Figure Global CTC Enrichment Price (2013-2018) Figure Global CTC Detection Sales Growth (2013-2018) Figure Global CTC Detection Price (2013-2018) Figure Global CTC Analysis Sales Growth (2013-2018) Figure Global CTC Analysis Price (2013-2018) Table Global Circulating Tumor Cell Diagnostics Sales by Application (2013-2018) Table Global Circulating Tumor Cell Diagnostics Sales Share by Application (2013-2018) Figure Global EMT biomarkers development Sales Growth (2013-2018) Figure Global Cancer stem cell research Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Circulating Tumor Cell Diagnostics Sales, Revenue and Growth Rate (2018-2023) Table Global Circulating Tumor Cell Diagnostics Sales Forecast by Regions (2018-2023) Table Global Circulating Tumor Cell Diagnostics Market Share Forecast by Regions (2018-2023) Figure North America Sales Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) Figure Europe Sales Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) Figure Asia-Pacific Sales Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) Figure South America Sales Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) Figure Middle East and Africa Sales Circulating Tumor Cell Diagnostics Market Forecast (2018-2023) Table Global Circulating Tumor Cell Diagnostics Sales Forecast by Type (2018-2023) Table Global Circulating Tumor Cell Diagnostics Market Share Forecast by Type (2018-2023) Table Global Circulating Tumor Cell Diagnostics Sales Forecast by Application (2018-2023) Table Global Circulating Tumor Cell Diagnostics Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Janssen Diagnostics Advanced Cell Diagnostics Aviva Biosciences Biocept Inc Biofluidica Inc. CellTraffix Inc. Clearbridge BioMedics Pte Ltd Epic Sciences Inc. Fluxion Biosciences Inc. ScreenCell Silicon Biosystems Sysmex Corporation Greiner Bio-One GmbH AdnaGen AG Apocell Inc Biocep Ltd Canopus Bioscience Ltd Creatv Microtech Inc Ikonisys Inc IV Diagnostics Inc Miltenyi Biotech GmbH Nanostring Technologies Inc Rarecells Diagnostics. Vitatex Inc